LBCT: Effects of Sacubitril/Valsartan in Women Compared to Men With Heart Failure and Preserved Ejection Fraction

被引：0
|
作者：
McMurray, John J. [1 ]
Lam, Carolyn S. [2 ,3 ]
McGrath, Martina [4 ]
Pardeep, Jhund S. [1 ]
O'Meara, Eileen [5 ]
Packer, Milton, Jr. [6 ]
Redfield, Margaret M. [7 ]
Shi, Victor [8 ]
Sweitzer, Nancy K. [9 ]
Solomon, Scott D. [10 ]
机构：
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[2] Natl Heart Ctr Singapore, Natl Heart Ctr, Singapore, Singapore
[3] Duke Natl Univ Singapore, Singapore, Singapore
[4] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA
[5] Montreal Heart Inst, Dept Med, Montreal, PQ, Canada
[6] Baylor Heart & Vasc Inst, Dallas, TX USA
[7] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Arizona, Tucson, AZ USA
[10] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
CIRCULATION | 2019年 / 140卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20984
引用
收藏
页码：E994 / E995
页数：2
相关论文
共 50 条
  • [1] Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction Insights From PARAGON-HF
    McMurray, John J., V
    Jackson, Alice M.
    Lam, Carolyn S. P.
    Redfield, Margaret M.
    Anand, Inder S.
    Ge, Junbo
    Lefkowitz, Marty P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Pfeffer, Marc A.
    Pieske, Burkert
    Rizkala, Adel R.
    Sabarwal, Shalini, V
    Shah, Amil M.
    Shah, Sanjiv J.
    Shi, Victor C.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Cikes, Maja
    Goncalvesova, Eva
    Katova, Tzvetana
    Kosztin, Anamaria
    Lelonek, Malgorzata
    Sweitzer, Nancy
    Vardeny, Orly
    Claggett, Brian
    Jhund, Pardeep S.
    Solomon, Scott D.
    CIRCULATION, 2020, 141 (05) : 338 - 351
  • [2] Sacubitril/Valsartan in heart failure with preserved ejection fraction in women and lower-range preserved ejection fraction
    Dachs, T.
    Nagele, F.
    Rettl, R.
    Dalos, D.
    Duca, F.
    Binder-Rodriguez, C.
    Camuz-Ligios, L.
    Dusik, F.
    Seirer, B.
    Hengstenberg, C.
    Bonderman, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S206 - S207
  • [3] Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
    Selvaraj, Senthil
    Claggett, Brian L.
    Packer, Milton
    Zannad, Faiez
    Anand, Inder S.
    Pieske, Burkert
    Zhao, Ziqiang
    Shi, Victor C.
    Lefkowitz, Martin P.
    McMurray, John J., V
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (17):
  • [4] Prior Heart Failure Hospitalization, Clinical Outcomes, and Effect of Sacubitril/Valsartan Compared With Valsartan in Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Claggett, Brian
    Anker, Stefan D.
    Perrone, Sergio V., Sr.
    Janssens, Stefan P.
    Milicic, Davor
    Arango, Juan L.
    Packer, Milton
    McMurray, John J.
    Solomon, Scott
    CIRCULATION, 2019, 140 (25) : E995 - E996
  • [5] Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction
    De Angelis, A.
    Cappetta, D.
    Telesca, M.
    Bellocchio, G.
    Urbanek, K.
    Berrino, L.
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [6] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [7] The effects of sacubitril/valsartan on heart failure with preserved ejection fraction: a meta-analysis
    Jiao Yuheng
    Li Yanyan
    Zhang Song
    Zha Yafang
    Meng Xiaowei
    Zhang Jiayan
    ACTA CARDIOLOGICA, 2022, 77 (06) : 471 - 479
  • [8] Progress and prospects of Sacubitril/Valsartan: Based on heart failure with preserved ejection fraction
    Jia, Ruoyu
    Ji, Ying
    Sun, Dong
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [9] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction
    Greene, Stephen J.
    Fonarow, Gregg C.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2994 - 2997
  • [10] Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction
    Tai, Andrew
    Ambrosy, Andrew P.
    Fudim, Marat
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E5 - E6
12345